A randomized, double-blind, placebo-controlled, phase 1/2a study of the safety and immunogenicity of a live, attenuated human parainfluenza virus type 3 vaccine in healthy infants - Bernstein, David I.; Falloon, Judith; Yi, Tingting (Vaccine, 2011)